FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2556754837> ?p ?o ?g. }

• W2556754837 endingPage "1966" @default.
• W2556754837 startingPage "1959" @default.
• W2556754837 abstract "Glioblastoma multiform (GBM) is one of the most common and highly aggressive primary brain tumors that thought to be of glial cells origin. The new available therapy for glioblastoma is based on better understanding of molecular malignant progression in this tumor. It is better to identify key molecular targets stimulating signaling pathways that lead to initiation of apoptosis for treatment of glioblastoma. Tumorigenesis broadly is controlled by tumor microenvironment and design of best biomimetic culture systems dependency on these conditions allow for in vitro and in vivo tumor modeling for studies of cancer cells behavior to drugs. We engineered three-dimensional (3D) human tumor models using U87 glioma cells in fibrin gel that mimic microenvironmental feature of glioblastoma in vivo. In this study, atorvastatin was used as a kind of statins for induction of apoptosis, and inhibition of migration and invasion in glioma cells.To reach for these aims, 3D model of glioma in fibrin gel was used with different concentrations of atorvastatin (1, 5, 10μM) to assay apoptotic genes expression by real time PCR and Tunel assay. After 24 and 48h exposing with different concentrations of atorvastatin, cell migration and invasion of tumor cells were investigated.The results showed atorvastatin induced apoptosis of glioma spheroids dose- dependently. The most likely mechanisms are the induction of apoptosis by caspase-8- caspase-3 signaling pathway. The invasion and migration of U87 spheroid cells decreased after 48h especially with 10μM concentration of atorvastatin.Finally these results suggest that this biomimetic model with fibrin may provide a vastly applicable 3D culture system to study the effect of anti-cancer drugs such as atrovastatin on tumor malignancy in vitro and in vivo and atorvastatin could be used as anticancer agent for glioblastoma treatment." @default.
• W2556754837 created "2016-11-30" @default.
• W2556754837 creator A5000143280 @default.
• W2556754837 creator A5011283022 @default.
• W2556754837 creator A5022887690 @default.
• W2556754837 creator A5032766635 @default.
• W2556754837 creator A5044453202 @default.
• W2556754837 creator A5045559282 @default.
• W2556754837 creator A5051169198 @default.
• W2556754837 creator A5056834183 @default.
• W2556754837 creator A5071916787 @default.
• W2556754837 date "2016-12-01" @default.
• W2556754837 modified "2023-09-23" @default.
• W2556754837 title "Apoptotic effect of atorvastatin in glioblastoma spheroids tumor cultured in fibrin gel" @default.
• W2556754837 cites W1553059007 @default.
• W2556754837 cites W1964923339 @default.
• W2556754837 cites W1966202238 @default.
• W2556754837 cites W1966941990 @default.
• W2556754837 cites W197014098 @default.
• W2556754837 cites W1974198171 @default.
• W2556754837 cites W1976457544 @default.
• W2556754837 cites W1979295144 @default.
• W2556754837 cites W1985670322 @default.
• W2556754837 cites W1990063973 @default.
• W2556754837 cites W1990676663 @default.
• W2556754837 cites W1995478441 @default.
• W2556754837 cites W2000744297 @default.
• W2556754837 cites W2005675505 @default.
• W2556754837 cites W2010542459 @default.
• W2556754837 cites W2013180434 @default.
• W2556754837 cites W2014994637 @default.
• W2556754837 cites W2015292819 @default.
• W2556754837 cites W2015538356 @default.
• W2556754837 cites W2030414680 @default.
• W2556754837 cites W2034937201 @default.
• W2556754837 cites W2039233803 @default.
• W2556754837 cites W2043234656 @default.
• W2556754837 cites W2043673063 @default.
• W2556754837 cites W2044722516 @default.
• W2556754837 cites W2049818544 @default.
• W2556754837 cites W2053456356 @default.
• W2556754837 cites W2058096164 @default.
• W2556754837 cites W2059621790 @default.
• W2556754837 cites W2063313335 @default.
• W2556754837 cites W2063332428 @default.
• W2556754837 cites W2072367771 @default.
• W2556754837 cites W2095578202 @default.
• W2556754837 cites W2096287682 @default.
• W2556754837 cites W2097786201 @default.
• W2556754837 cites W2107055927 @default.
• W2556754837 cites W2108001188 @default.
• W2556754837 cites W2109063792 @default.
• W2556754837 cites W2110798171 @default.
• W2556754837 cites W2126564019 @default.
• W2556754837 cites W2130314209 @default.
• W2556754837 cites W2141614615 @default.
• W2556754837 cites W2142332846 @default.
• W2556754837 cites W2144320863 @default.
• W2556754837 cites W2145376550 @default.
• W2556754837 cites W2162703019 @default.
• W2556754837 cites W2166249402 @default.
• W2556754837 cites W2274625634 @default.
• W2556754837 cites W4250060927 @default.
• W2556754837 doi "https://doi.org/10.1016/j.biopha.2016.11.003" @default.
• W2556754837 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27836464" @default.
• W2556754837 hasPublicationYear "2016" @default.
• W2556754837 type Work @default.
• W2556754837 sameAs 2556754837 @default.
• W2556754837 citedByCount "31" @default.
• W2556754837 countsByYear W25567548372017 @default.
• W2556754837 countsByYear W25567548372018 @default.
• W2556754837 countsByYear W25567548372019 @default.
• W2556754837 countsByYear W25567548372020 @default.
• W2556754837 countsByYear W25567548372021 @default.
• W2556754837 countsByYear W25567548372022 @default.
• W2556754837 countsByYear W25567548372023 @default.
• W2556754837 crossrefType "journal-article" @default.
• W2556754837 hasAuthorship W2556754837A5000143280 @default.
• W2556754837 hasAuthorship W2556754837A5011283022 @default.
• W2556754837 hasAuthorship W2556754837A5022887690 @default.
• W2556754837 hasAuthorship W2556754837A5032766635 @default.
• W2556754837 hasAuthorship W2556754837A5044453202 @default.
• W2556754837 hasAuthorship W2556754837A5045559282 @default.
• W2556754837 hasAuthorship W2556754837A5051169198 @default.
• W2556754837 hasAuthorship W2556754837A5056834183 @default.
• W2556754837 hasAuthorship W2556754837A5071916787 @default.
• W2556754837 hasBestOaLocation W25567548371 @default.
• W2556754837 hasConcept C121608353 @default.
• W2556754837 hasConcept C128473837 @default.
• W2556754837 hasConcept C150903083 @default.
• W2556754837 hasConcept C175369904 @default.
• W2556754837 hasConcept C185592680 @default.
• W2556754837 hasConcept C190283241 @default.
• W2556754837 hasConcept C196795494 @default.
• W2556754837 hasConcept C202751555 @default.
• W2556754837 hasConcept C203014093 @default.
• W2556754837 hasConcept C207001950 @default.
• W2556754837 hasConcept C2777482532 @default.

• next